209 related articles for article (PubMed ID: 23879859)
1. Tunable heparan sulfate mimetics for modulating chemokine activity.
Sheng GJ; Oh YI; Chang SK; Hsieh-Wilson LC
J Am Chem Soc; 2013 Jul; 135(30):10898-901. PubMed ID: 23879859
[TBL] [Abstract][Full Text] [Related]
2. Expedient Synthesis of Core Disaccharide Building Blocks from Natural Polysaccharides for Heparan Sulfate Oligosaccharide Assembly.
Pawar NJ; Wang L; Higo T; Bhattacharya C; Kancharla PK; Zhang F; Baryal K; Huo CX; Liu J; Linhardt RJ; Huang X; Hsieh-Wilson LC
Angew Chem Int Ed Engl; 2019 Dec; 58(51):18577-18583. PubMed ID: 31553820
[TBL] [Abstract][Full Text] [Related]
3. Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins.
Freeman C; Liu L; Banwell MG; Brown KJ; Bezos A; Ferro V; Parish CR
J Biol Chem; 2005 Mar; 280(10):8842-9. PubMed ID: 15632177
[TBL] [Abstract][Full Text] [Related]
4. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.
Veraldi N; Zouggari N; de Agostini A
Molecules; 2020 Jan; 25(2):. PubMed ID: 31963505
[TBL] [Abstract][Full Text] [Related]
5. Single-entity heparan sulfate glycomimetic clusters for therapeutic applications.
Tyler PC; Guimond SE; Turnbull JE; Zubkova OV
Angew Chem Int Ed Engl; 2015 Feb; 54(9):2718-23. PubMed ID: 25640820
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.
Sutton A; Friand V; Papy-Garcia D; Dagouassat M; Martin L; Vassy R; Haddad O; Sainte-Catherine O; Kraemer M; Saffar L; Perret GY; Courty J; Gattegno L; Charnaux N
Mol Cancer Ther; 2007 Nov; 6(11):2948-58. PubMed ID: 18025279
[TBL] [Abstract][Full Text] [Related]
7. Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.
Lanzi C; Cassinelli G
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413079
[TBL] [Abstract][Full Text] [Related]
8. Novel heparan sulfate mimetic compounds as antitumor agents.
Ishida K; Wierzba MK; Teruya T; Simizu S; Osada H
Chem Biol; 2004 Mar; 11(3):367-77. PubMed ID: 15123266
[TBL] [Abstract][Full Text] [Related]
9. A biophysical insight into the RANTES-glycosaminoglycan interaction.
Rek A; Brandner B; Geretti E; Kungl AJ
Biochim Biophys Acta; 2009 Apr; 1794(4):577-82. PubMed ID: 19455751
[TBL] [Abstract][Full Text] [Related]
10. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization.
Vivès RR; Sadir R; Imberty A; Rencurosi A; Lortat-Jacob H
Biochemistry; 2002 Dec; 41(50):14779-89. PubMed ID: 12475226
[TBL] [Abstract][Full Text] [Related]
11. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
12. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.
Dyer DP; Salanga CL; Volkman BF; Kawamura T; Handel TM
Glycobiology; 2016 Mar; 26(3):312-26. PubMed ID: 26582609
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells.
Papy-Garcia D; Albanese P
Glycoconj J; 2017 Jun; 34(3):377-391. PubMed ID: 28577070
[TBL] [Abstract][Full Text] [Related]
14. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity.
Loka RS; Yu F; Sletten ET; Nguyen HM
Chem Commun (Camb); 2017 Aug; 53(65):9163-9166. PubMed ID: 28766595
[TBL] [Abstract][Full Text] [Related]
16. Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development.
Shanthamurthy CD; Leviatan Ben-Arye S; Kumar NV; Yehuda S; Amon R; Woods RJ; Padler-Karavani V; Kikkeri R
J Med Chem; 2021 Mar; 64(6):3367-3380. PubMed ID: 33683903
[TBL] [Abstract][Full Text] [Related]
17. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
Rudd TR; Uniewicz KA; Ori A; Guimond SE; Skidmore MA; Gaudesi D; Xu R; Turnbull JE; Guerrini M; Torri G; Siligardi G; Wilkinson MC; Fernig DG; Yates EA
Org Biomol Chem; 2010 Dec; 8(23):5390-7. PubMed ID: 20865198
[TBL] [Abstract][Full Text] [Related]
18. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
[TBL] [Abstract][Full Text] [Related]
19. Rational Design and Expedient Synthesis of Heparan Sulfate Mimetics from Natural Aminoglycosides for Structure and Activity Relationship Studies.
Wakpal J; Pathiranage V; Walker AR; Nguyen HM
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202304325. PubMed ID: 37285191
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in heparan sulfate during muscle differentiation and ageing regulate myoblast cell fate and FGF2 signalling.
Ghadiali RS; Guimond SE; Turnbull JE; Pisconti A
Matrix Biol; 2017 May; 59():54-68. PubMed ID: 27496348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
